Literature DB >> 7578517

Intraperitoneal antibiotics effectively treat non-dialysis-related infections.

T Gorman, G Eisele, G R Bailie.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7578517

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

1.  The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.

Authors:  M Kussmann; L Schuster; M Zeitlinger; P Pichler; G Reznicek; M Wiesholzer; H Burgmann; W Poeppl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-04       Impact factor: 3.267

2.  Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.

Authors:  Manuel Kussmann; Linda Schuster; Sarah Wrenger; Petra Pichler; Gottfried Reznicek; Heinz Burgmann; Wolfgang Poeppl; Markus Zeitlinger; Martin Wiesholzer
Journal:  Perit Dial Int       Date:  2016-09-28       Impact factor: 1.756

3.  Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.

Authors:  M Kussmann; A Baumann; S Hauer; P Pichler; M Zeitlinger; M Wiesholzer; H Burgmann; W Poeppl; G Reznicek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-06       Impact factor: 3.267

4.  Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.

Authors:  Manuel Kussmann; Alexander Ferth; Markus Obermüller; Petra Pichler; Markus Zeitlinger; Martin Wiesholzer; Heinz Burgmann; Wolfgang Poeppl; Gottfried Reznicek
Journal:  Sci Rep       Date:  2019-04-24       Impact factor: 4.379

5.  Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.

Authors:  Manuel Kussmann; Stefan Hauer; Petra Pichler; Gottfried Reznicek; Heinz Burgmann; Wolfgang Poeppl; Markus Zeitlinger; Martin Wiesholzer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-15       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.